万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/13653164
3、投稿网址：http://mc.manuscriptcentral.com/vde
4、官网邮箱：VDEedoffice@wiley.com（编辑部）
5、期刊刊期：双月刊，逢双月出版。
2021年6月30日星期三
投稿须知【官网信息】
Author Guidelines
1. GENERAL COMMENTS, AIMS, SCOPE
Veterinary Dermatology is a bi-monthly, peer-reviewed, international journal which publishes papers on all aspects of the skin of mammals, birds, reptiles, amphibians and fish such as:
Skin structure (anatomy, histology, ultrastructure)
Skin function (physiology, biochemistry, pharmacology, immunology, genetics)
Skin ecosystem, microbiology and parasitology relevant to skin
Dermatopathology
Pathogenesis, diagnosis and treatment, including prophylaxis, of skin diseases
New skin disease entities
The journal is available online and as hardcopy and publishes:
Scientific research papers
Brief communications
Clinical case reports
Invited reviews
Special feature articles (e.g. “Clinical Techniques”, “Histopathology Corner”)
Letters, book reviews and editorials
Submission to Veterinary Dermatology implies that the content has not been published or submitted for publication elsewhere except as a brief (maximum 250 word) abstract in the proceedings of a scientific meeting or symposium. Studies reporting negative results (i.e. null hypothesis cannot be rejected) will also be considered providing the study design is sufficiently robust relevant to the journal.
2. MANUSCRIPT TYPES
The requirements for each manuscript type are described below and summarised in the table with more specific recommendations on manuscript preparation and formatting under section 4
Scientific research papers are original experimental or observational studies that present novel results and conclusions or advances within the scope of this journal. Articles have a separate structured abstract of up to 250 words, followed by an Introduction, Materials and methods, Results, Discussion, Conclusions, Acknowledgements, References and in some cases Supporting information. Articles should be no longer than 3000 words, excluding title page, abstract, figure and table legends, acknowledgement and references, and they can include six display items (figures or tables). Additional information can be published as Supporting Information (online only) but may not undergo the same copyediting processes by the editorial team.
Brief Communications report novel or important findings or clarifications in a concise format. The text (excluding title page, abstract and references) is limited to 1500 words with up to 12 references. For some manuscripts the editors may ask to reduce the word count to 750 and up to six references. Up to four display items (figures or tables) can be included.
Case Reports will only be considered for publication if they add new and useful information for the discipline of veterinary dermatology. The word limit for all case reports is limited to 750 words, excluding title page, abstract, acknowledgement and references. The main text must focus solely on novel key information provided by the case(s). Relevant additional information may be submitted as Supporting Information (published online, not in print). Such Supporting information may for example include detail of diagnostic procedures or treatment that can generally be considered as widely accepted in veterinary dermatology practice or a chronological description of progress. Up to four display items (figures or tables) can be included. No more than six references are recommended, up to twelve may be acceptable at the editor’s discretion. Consideration will be given to reports:
of new diseases or conditions, or of variations on recently described diseases
of diseases that are of zoonotic importance or are highly contagious
that will make a significant change in how a disease is diagnosed or treated.
Case series should be submitted in the format of Case Reports but submission as a Scientific Paper may be considered after discussion with the editors.
Letters to the Editor providing comments on previously published papers or seeking to generate discussion or awareness of a developing area are welcomed. Comments on previously published papers should be confined to the substance of the paper and the authors of the paper referred to will be offered the opportunity to respond. If the authors do not want to provide a response, or do not provide a response within 30 days, an Editor's footnote will be added to the published Letter to the Editor (e.g., “The authors of [title of previously published paper] offered no comments".) Letters should only present new data if the data supports a comment raised about the paper referred to. Authors who would like to present new data should submit as a Brief Communication instead.
The journal requires that all authors disclose any potential sources of conflict of interest. The existence of a conflict of interest does not preclude publication. It is the responsibility of the corresponding author to review the journal’s conflict of interest policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships. If the author(s) have no conflicts of interest to declare, this must also be stated.
Letters will be limited to 750 words, including references, and up to two display items (figure or table).
Review articles are by invitation from the Editor-in-Chief and after approval from the editorial team. The structure will vary depending on content, but manuscripts should not exceed 6000 words unless agreed with the editors before submission. Authors wanting to propose a topic for review or to submit a review article should contact the Editor-in-Chief (via VDEedoffice@wiley.com) with a brief description of the article and outline.
Book reviews will be invited by the editors. Books proposed for review can be discussed with the editors.
Education articles are articles such as “Clinical Techniques”, “Histopathology Corner” or editorials. They are by invitation from the editors and advice on formatting will be provided as appropriate for the topic. During the submission process, please upload as 'Education'.
Summary of manuscript structure
Abstract
Word limit
Display items (figures or tables)
References
Scientific paper
Structured and up to 250 words
3000* (or as discussed with the editors)
Around 6
Typically no more than 50
Brief communication or short case series
Structured and up to 250 words
1500* (750 may be advised by an editor)
Up to 4
Up to 12, six if 750 words
Case report
Narrative and up to 50 words
750*
Up to 4
Up to six (12 at editor’s discretion)
Letter to the Editor
None
750 (including title and references)
Up to 2
Up to 6
Review – by invitation
Can be truncated or structured and up to 250
Up to 6000* (or as discussed with the editors)
As appropriate
As appropriate
Book review
Information provided by the editors
Education articles
'Clinical Techniques' or 'Histopathology Corner' feature articles. By invitation. Information on formatting will be provided by the editors depending on topic of the article. During the submission process, please upload as 'Education'
*excluding title page, abstract, figure and table legends, acknowledgement and references
For all types of contributions, relevant Supporting information containing additional text and figures may be allowed. All Supporting information should be referenced in the text. It will be peer reviewed but only published online. Supporting information, if extensive, may not undergo the journal’s full copyediting process, primary responsibility for clear formatting lies with the authors and editors may ask the authors to edit the material prior to publication.
www.wiley.com/go/nihmandate
3. ETHICS REQUIREMENTS FOR STUDIES INVOLVING ANIMALS
All material published in Veterinary Dermatology must adhere to high ethical standards on animal welfare as set out by the International Association of Veterinary Editors (IAVE), available at http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors/
Authors are responsible for including information on provision of best practice and animal welfare in the manuscript and – if requested by the editors – provide evidence for compliance with these requirements prior to peer review or publication.
For all studies involving invasive procedures, analgesia, sedation and/or anaesthesia must always be used as appropriate and such use must be clearly described. The Editors retain the right to reject manuscripts when, in their opinion, studies involved unnecessary pain, distress, suffering or lasting harm to animals or where the relevant guidelines were not followed. In addition, the Editors would not normally support publication of experiments resulting in euthanasia. They will collaborate, if required, with institutions and other organizations that investigate cases of suspected research misconduct following: COPE guidance.
Which animal studies require ethical oversight?
For the purpose of publishing in Veterinary Dermatology, ethical considerations and their inclusion in a manuscript are required for:
Clinical studies involving client-owned animals if the study design classifies a study as research (e.g. if animals are randomised into groups). Ethical oversight and approval are required even if the outcome of the study (e.g. the efficacy of a new treatment, or accuracy of a diagnostic tests) is either for the direct benefit of the animals under treatment, or their immediate group. Ethical approval is NOT required if established internationally recognised high standards (“best practice”) of individual veterinary patient care were followed.
All studies on experimental animals where there is no direct benefit to the animals or their immediate group and where the procedures used may cause pain, suffering, distress or lasting harm. Animals used for these scientific purposes are protected by national legislation and/or regulations.
In vitro studies using tissue from animals or humans (e.g. skin biopsy samples, serum, faeces) where the origin of samples needs to be confirmed as compliant with requirements for “best practice” or ethics guidelines.
Studies using non-invasive procedures (e.g. swabbing for microbial skin carriage) if personal identifiable data from owners were collected during the study (informed verbal or written consent will be a minimum requirement for publication).
Research where the results, even if obtained by non-invasive methods (e.g. work done on swab, faecal, serum samples), may have implications for human health, e.g. for studies screening for zoonotic pathogens, how was the reporting of results communicated to owners?
Authors are asked to:
At submission,
confirm that animal use was conducted in accordance with international, national and institutional guidelines for the humane treatment of animals, and in compliance with relevant legislation
Provide the name of any approving body, institutional reference number or approved protocol number where applicable
confirm that written consent was obtained from animal owners for studies using privately/client-owned animals (or declare that this was not required for their study).
Include in the ‘Materials and Methods’ section of the manuscript,
a statement on whether ethical considerations were required for the study
if yes, include as the first paragraph of the ‘Materials and Methods’ section under the subheading “Ethics” sufficient detail on the ethics review and approval to allow assessment of the process. The section needs to include that written informed owner consent was obtained.
Specific comments on what is required
Client/privately-owned animals: all studies to be considered for publication in Veterinary Dermatology must have followed internationally recognized “best clinical practice” standards for veterinary patient care and procedures must be described in the ‘Materials and Methods’ section (first subheading “Ethics”). Authors need to describe how the institutional, national and/or international guidelines were met (including name of approving body and institutional), and details of how animal welfare standards/best veterinary practice standards were met (names of ethical oversight bodies need to be hidden for confidentiality until acceptance as for other identifiers in the manuscript). Authors must ensure that owner consent for use of images has been given where animals may be identifiable.
Where veterinary interventions went beyond “best clinical practice” for individual patients, approval by an institutional ethics review/oversight committee will be required and authors must be able to confirm that informed, appropriately worded written consent had been obtained from animal owners prior to study begin.
The description in the manuscript needs to include how owners’ confidentiality was ensured.
Where an institutional ethics review/oversight board is not directly accessible to authors, a moral obligation of achieving these standards remains and other arrangements must be made for this to take place before study begin. Authors working in private practice are encouraged to seek suitable external assessment from national professional organisations, e.g.
by consulting with and involving a colleague with relevant experience at a reputable institution or a university or veterinary school with access to an oversight committee.
in the UK, clinicians who wish to conduct clinical trials, and do not have access to a university ethical review, may submit study plans to the Royal College of Veterinary Surgeons for review by its ethical review panel https://www.rcvs.org.uk/who-we-are/committees/ethics-review-panel/ For example, by the ethical review committee at a reputable institution such as a university or veterinary school.
By recruiting the oversight of an ad hoc ethical committee. Detail must be provided in the manuscript on the nature of an ad hoc committee used (and which must have included at least some individuals independent of the institute(s)/clinic(s) involved in the work.
As a minimum requirement, authors will be asked to discuss with the editors (and describe in the Methods) that they have searched for suitable external assessment and that their research was conducted in a manner likely to be approved by ethics committees/boards in most countries.
All research involving experimental animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted and be compliant with national regulations. Also, several internationally accepted guidance documents are available and should be followed:
The international Guiding Principles for Biomedical Research Involving Animals (1985) from the Council for International Organizations of Medical Sciences, available at https://cioms.ch/shop/product/international-guiding-principles-for-biomedical-research-involving-animals-2/ (or from the Executive Secretary CIOMS, c/o WHO, Via Appia, CH-1211 Geneva 27, Switzerland)
For planning of animal experiments the PREPARE guidance and for reporting of animal research the ARRIVE guidance as detailed in the links below:
PREPARE (Planning Research and Experimental Procedures on Animals): Recommendations for Excellence) guidelines: https://norecopa.no/prepare
PREPARE checklist: https://norecopa.no/media/7864/prepare_checklist_english.pdf
ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines: https://www.nc3rs.org.uk/arrive-guidelines . These were developed by the NC3Rs to improve standards of reporting and ensure that the data from animal experiments can be fully evaluated and utilised.
ARRIVE checklist: https://www.nc3rs.org.uk/sites/default/files/documents/Guidelines/NC3Rs%20ARRIVE%20Guidelines%20Checklist%20(fillable).pdf
If authors are from within the EU, the ethical and welfare standards of the work must at least reach those required by the Directive 2010/63/EU on the protection of animals used for scientific purposes. Text with EEA relevance: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32010L0063 . Within this Directive (under Article 49), Member States are asked to establish national committees for the protection of animals used for scientific purposes to exchange information on the operation of animal welfare bodies and project evaluation and share best practice within the Union. Links to already established authorities are included for many countries: http://ec.europa.eu/environment/chemicals/lab_animals/nc_en.htm
For the UK in particular, authors need to conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039): https://www.legislation.gov.uk/ukpga/1986/14/contents
Authors from the USA should cite compliance with US Institutional Animal Care and Use Committees (or IACUCs)(See: https://www.aalas.org/iacuc ) as applicable. Specifically, experiments and clinical trials should be carried out in accordance with the Guidelines by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures (https://www.ncbi.nlm.nih.gov/pubmed/21595115 ) and https://olaw.nih.gove/guidance/fags
For authors from countries where an ethical review/oversight body is not readily available, this should be stated and the nature of alternatives sought, e.g. of an ad hoc committee used for this purpose should be described (which must have included at least some individuals independent of the institute(s)/clinic(s) involved in the work).
4. HOW TO PREPARE AND FORMAT YOUR MANUSCRIPT FOR VETERINARY DERMATOLOGY
On submission, authors will be prompted to:
use an ORCID iD (Open Researcher and Contributor ID, a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.
Provide contact details and academic affiliations for all authors and identify the corresponding author. Details must match those listed on the title page (see below) which is to be submitted separately to allow blinded peer review.
Confirm originality and compliance with ethical requirements
State funding sources
List three recommended reviewers and can also (optional) list opposed reviewers - these suggestions will not be binding for the editors)
Authors are encouraged to consult Wiley’s free online guidance resources on writing for publication or language and style guides. We strongly recommend that authors familiarise themselves with Veterinary Dermatology’s style and format by reading a recent issue of the journal online or as hard copy. Correct preparation and formatting will improve the review and publication process and help to avoid delays.
All manuscripts
Separate files should be submitted, as appropriate, in the following order:
Title page (includes details of authors, funding, conflicts of interest, acknowledgements as detailed below)
Main text file (designated Main Document during upload)
Tables
Figures
Supporting Information
Manuscripts (including references, figure and table legends) must be submitted as A4 or 8.5 x 11 inch format with 2.5 cm margins, single-spaced typed, align text left, 12 point font using sans serif typeface such as Helvetica (Swiss), Arial or Verdana style (please do not use Times New Roman). Each line and page should be numbered in the manuscript text.
As Veterinary Dermatology operates a system of double-blinded review, authors should avoid including identifiers within the main text file: the name of the institution at which the work was performed, initials of the authors; and must remove institution names from illustrations in order to maintain anonymity. Please include these details on the title page.
Title Page
A Title Page should be submitted as a separate file for all types of contributions. It will not be forwarded to the reviewers and should contain:
A short informative title. The title should not contain abbreviations or tradenames of drugs (see Wiley's best practice SEO tips);
A short running title of less than 50 characters
The full names of the authors;
The authors’ institutional affiliations where the work was conducted. Where authors have moved to different addresses since, please also provide their current address.
Authors can stipulate if they share first authorship or senior authorship
Acknowledgements.
The Acknowledgments section should list contributions from anyone who does not meet the criteria for authorship, with permission from the contributor. This will include any details of writing assistance companies and who funded this.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/13653164/homepage/forauthors.html
